These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1145 related articles for article (PubMed ID: 30350585)

  • 21. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents.
    Gugliotta G; Botta M; Tei L
    Org Biomol Chem; 2010 Oct; 8(20):4569-74. PubMed ID: 20740241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basic MR relaxation mechanisms and contrast agent design.
    De León-Rodríguez LM; Martins AF; Pinho MC; Rofsky NM; Sherry AD
    J Magn Reson Imaging; 2015 Sep; 42(3):545-65. PubMed ID: 25975847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of q-values and conformations of gadolinium chelates for magnetic resonance imaging.
    Castonguay LA; Treasurywala AM; Caulfield TJ; Jaeger EP; Kellar KE
    Bioconjug Chem; 1999; 10(6):958-64. PubMed ID: 10563764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of approved MR contrast media for intravenous injection.
    Runge VM
    J Magn Reson Imaging; 2000 Aug; 12(2):205-13. PubMed ID: 10931582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
    Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
    Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E; Negri V; Soler-Padrós J; Cerdán S; Ballesteros P
    Eur J Radiol; 2008 Sep; 67(3):453-8. PubMed ID: 18455343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
    Caravan P
    Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in metal-based probes for MR molecular imaging applications.
    Terreno E; Dastrù W; Delli Castelli D; Gianolio E; Geninatti Crich S; Longo D; Aime S
    Curr Med Chem; 2010; 17(31):3684-700. PubMed ID: 20846110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New aromatic macrocyclic gadolinium chelates with enhanced relaxivity.
    Zhang X; Pillai R; Shukla R; Ranganathan RS; Tweedle M
    Invest Radiol; 1994 Jun; 29 Suppl 2():S69-70. PubMed ID: 7928275
    [No Abstract]   [Full Text] [Related]  

  • 30. High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-beta-cyclodextrin.
    Battistini E; Gianolio E; Gref R; Couvreur P; Fuzerova S; Othman M; Aime S; Badet B; Durand P
    Chemistry; 2008; 14(15):4551-61. PubMed ID: 18386282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications for Transition-Metal Chemistry in Contrast-Enhanced Magnetic Resonance Imaging.
    Gupta A; Caravan P; Price WS; Platas-Iglesias C; Gale EM
    Inorg Chem; 2020 May; 59(10):6648-6678. PubMed ID: 32367714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRI micelles self-assembled from synthetic gadolinium-based nano building blocks.
    Babič A; Vorobiev V; Trefalt G; Crowe LA; Helm L; Vallée JP; Allémann E
    Chem Commun (Camb); 2019 Jan; 55(7):945-948. PubMed ID: 30604781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of High Relaxivity Gadolinium AAZTA Tetramers as Building Blocks for Bioconjugation.
    Tripepi M; Capuana F; Gianolio E; Kock FVC; Pagoto A; Stefania R; Digilio G; Aime S
    Bioconjug Chem; 2018 Apr; 29(4):1428-1437. PubMed ID: 29470084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadolinium-binding helix-turn-helix peptides: DNA-dependent MRI contrast agents.
    Caravan P; Greenwood JM; Welch JT; Franklin SJ
    Chem Commun (Camb); 2003 Oct; (20):2574-5. PubMed ID: 14594287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternatives to gadolinium-based metal chelates for magnetic resonance imaging.
    Viswanathan S; Kovacs Z; Green KN; Ratnakar SJ; Sherry AD
    Chem Rev; 2010 May; 110(5):2960-3018. PubMed ID: 20397688
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumor-Targeted and Clearable Human Protein-Based MRI Nanoprobes.
    Zhao Y; Peng J; Li J; Huang L; Yang J; Huang K; Li H; Jiang N; Zheng S; Zhang X; Niu Y; Han G
    Nano Lett; 2017 Jul; 17(7):4096-4100. PubMed ID: 28581764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of conformationally rigid dimeric MRI agents.
    Shukla R; Fernandez M; Pillai RK; Ranganathan R; Ratsep PC; Zhang X; Tweedle MF
    Magn Reson Med; 1996 Jun; 35(6):928-31. PubMed ID: 8744023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective anchoring of Gd(III) chelates on the external surface of organo-modified mesoporous silica nanoparticles: a new chemical strategy to enhance relaxivity.
    Carniato F; Tei L; Arrais A; Marchese L; Botta M
    Chemistry; 2013 Jan; 19(4):1421-8. PubMed ID: 23233428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Relaxivity contrast agents for magnetic resonance imaging based on multisite interactions between a beta-cyclodextrin oligomer and suitably functionalized GdIII chelates.
    Aime S; Botta IM; Fedeli F; Gianolio E; Terreno E; Anelli P
    Chemistry; 2001 Dec; 7(24):5261-9. PubMed ID: 11822426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents.
    Martin VV; Ralston WH; Hynes MR; Keana JF
    Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.